Decavèle, Maxens http://orcid.org/0000-0003-3552-5053
Gatulle, Nicolas
Weiss, Nicolas
Rivals, Isabelle
Idbaih, Ahmed
Demeret, Sophie
Mayaux, Julien
Dres, Martin
Morawiec, Elise
Hoang-Xuan, Khe
Similowski, Thomas
Demoule, Alexandre
Article History
Received: 12 July 2020
Revised: 24 August 2020
Accepted: 26 August 2020
First Online: 29 August 2020
Compliance with ethical standards
:
: Thomas Similowski reports personal fees from ADEP Assistance, AstraZeneca France, Boerhinger Ingelheim France, Chiesi France, GSK France, Lungpacer Inc., Novartis France, TEVA France, outside the submitted work; In addition, Dr. Similowski has a patent titled “brain–ventilator interface” licensed to Air Liquide Medical Systems and MyBrainTechnology, a patent for a “protection device for intubation” pending, and a patent for a “non-contact thoracic movement imaging system» pending. Alexandre Demoule reports personal fees from Medtronic, grants, personal fees, and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees, and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, and grants and non-financial support from Lungpacer, outside the submitted work. Martin Dres received personal fees and travel expenses from Lungpacer outside the submitted work. Nicolas Weiss has signed research contracts with Eumedica, BMS, MedDay pharmaceuticals; he has also received personal fees from Norgine and Alpha-Wasserman and Consultant fees from MedDay Pharmaceuticals. Ahmed Idbaih reports research funding from La Fondation ARC pour la recherche sur le Cancer, Carthera, Beta-Innov, and Intselchimos; travel funding from Hoffmann-La Roche; and personal fees from Novartis, La Lettre du Cancérologue, BMS, and Cipla unrelated to the submitted work. Other authors had no conflict of interest to declare.
: The study was approved by the French Intensive Care Society Institutional Review Board (CE SRLF 20-15) and information was given to the patients or their relatives.
: Our data are available to ensure transparency.
Free to read: This content has been made available to all.